Effects of reduced nicotine content cigarettes on individual withdrawal symptoms over time and during abstinence.
Ontology highlight
ABSTRACT: In the United States, the Food and Drug Administration (FDA) has initiated a public dialogue about reducing the nicotine content of cigarettes. A reduced-nicotine standard could increase withdrawal symptoms among current smokers. We examined the impact of switching smokers to cigarettes that varied in nicotine content on withdrawal symptoms over 6 weeks. A secondary analysis (N = 839) of a 10-site, double-blind clinical trial of nontreatment-seeking smokers was completed. Participants were instructed to smoke study cigarettes, containing 0.4 to 15.8 mg of nicotine/g of tobacco, for 6 weeks and were then abstinent overnight. Using latent growth curves, trajectories of individual withdrawal symptoms were compared between the reduced nicotine content (RNC) conditions and a normal nicotine con
SUBMITTER: Dermody SS
PROVIDER: S-EPMC5986583 | biostudies-literature | 2018 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA